In recent years, the hidradenitis suppurativa market is anticipated to grow rapidly during the forecast period. Hidradenitis suppurativa, often known as acne inversa, is a chronic dermatological condition characterized by swollen lumps. Hormonal imbalances, friction from clothing, and sweating cause hidradenitis suppurativa. According to a 2014 article published in Current Dermatology Reports, the condition is also caused by smoking, obesity, and genetic factors. Hence, the demand for hidradenitis suppurativa market is increased.
Frequently Asked Questions
The market is segmented based on Segmentation, By Clinical Stage (Hurley Stage 1, Hurley Stage 2, Hurley Stage 3), Skin Condition (Folliculitis, Pimples, Boils, Deep-Acne, Others), Treatment Type (Surgery, Medications, Photodynamic Therapy (PDT), Laser Treatment, Others), Route of Administration (Oral, Parenteral, Others), End-Users (Hospitals, Specialty Clinics, Homecare, Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Others) – Industry Trends and Forecast to 2032
.
The Global Hidradenitis Suppurativa Market size was valued at USD 799.49 USD Million in 2024.
The Global Hidradenitis Suppurativa Market is projected to grow at a CAGR of 4.7% during the forecast period of 2025 to 2032.
The market report covers data from the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
